{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:48:36Z","timestamp":1792511316425,"version":"4.5.0"},"reference-count":164,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.rmed.2025.108336","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:09:13Z","timestamp":1756768153000},"page":"108336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Noninfectious pulmonary complications after hematopoietic cell transplantation: a comprehensive review"],"prefix":"10.1016","volume":"248","author":[{"given":"Christopher","family":"Bertini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2126-8316","authenticated-orcid":false,"given":"Felipe","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Bashoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Shing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0702-7889","authenticated-orcid":false,"given":"Matthew K.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7050-6504","authenticated-orcid":false,"given":"Joe","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9954-722X","authenticated-orcid":false,"given":"Yu Kuang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2331-3961","authenticated-orcid":false,"given":"Husham","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2731-3299","authenticated-orcid":false,"given":"Jeffrey M.","family":"Sturek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Yanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1889-2524","authenticated-orcid":false,"given":"Hemang","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-3945","authenticated-orcid":false,"given":"Saadia A.","family":"Faiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-0180","authenticated-orcid":false,"given":"Ajay","family":"Sheshadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.rmed.2025.108336_bib1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3324\/haematol.2021.279189","article-title":"One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors","volume":"107","author":"Niederwieser","year":"2022","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/bmt.2016.18","article-title":"Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey","volume":"51","author":"Niederwieser","year":"2016","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1378\/chest.10-2889","article-title":"Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant","volume":"141","author":"Afessa","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib5","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib6","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1164\/rccm.200208-792OC","article-title":"Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients","volume":"166","author":"Afessa","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s12185-021-03282-9","article-title":"Risk factors and prognosis of non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation","volume":"115","author":"Onizuka","year":"2022","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/asheducation-2001.1.392","article-title":"Preventing opportunistic infections after hematopoietic stem cell transplantation: the centers for disease control and prevention, infectious diseases society of America, and American society for blood and marrow transplantation practice guidelines and Be","volume":"2001","author":"Sullivan","year":"2001","journal-title":"Hematology"},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib9","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/bloodadvances.2021004364","article-title":"The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States","volume":"6","author":"Sacks","year":"2022","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/bmt.2014.264","article-title":"Health-related quality of life in patients who develop bronchiolitis obliterans syndrome following allo-SCT","volume":"50","author":"Amin","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.36469\/9814","article-title":"Estimating the burden of cost in chronic graft-versus-host disease: a human capital approach","volume":"4","author":"Jones","year":"2016","journal-title":"J Health Econ. Outcomes Res."},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1513\/AnnalsATS.202008-1032OC","article-title":"Characteristics and outcome of periengraftment respiratory distress syndrome after autologous hematopoietic cell transplant","volume":"18","author":"Wieruszewski","year":"2021","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"10.1016\/j.rmed.2025.108336_bib13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bbmt.2005.04.009","article-title":"Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival","volume":"11","author":"Gorak","year":"2005","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"12","key":"10.1016\/j.rmed.2025.108336_bib14","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.bbmt.2015.08.030","article-title":"Engraftment syndrome after autologous stem cell transplantation: an update unifying the definition and management approach","volume":"21","author":"Cornell","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.bmt.1703784","article-title":"Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF)","volume":"31","author":"Akasheh","year":"2003","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib16","first-page":"175","article-title":"Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation","volume":"16","author":"Lee","year":"1995","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41409-020-01164-y","article-title":"Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation","volume":"56","author":"Bai","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"12","key":"10.1016\/j.rmed.2025.108336_bib18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.bmt.1703075","article-title":"Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation","volume":"27","author":"Capizzi","year":"2001","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"10.1016\/j.rmed.2025.108336_bib19","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.2007-413ST","article-title":"An official American thoracic society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome","volume":"183","author":"Panoskaltsis-Mortari","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib20","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1016\/j.transproceed.2005.10.101","article-title":"Etanercept therapy for late-onset idiopathic pneumonia syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Tun","year":"2005","journal-title":"Transplant. Proc."},{"issue":"11","key":"10.1016\/j.rmed.2025.108336_bib21","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.bbmt.2017.07.019","article-title":"Etanercept and corticosteroid therapy for the treatment of late-onset idiopathic pneumonia syndrome","volume":"23","author":"Thompson","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib22","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s12185-022-03417-6","article-title":"Incidence and predictors of idiopathic pneumonia syndrome in hematopoietic stem cell transplant patients: a nationwide registry study","volume":"116","author":"Liu","year":"2022","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bbmt.2019.09.034","article-title":"Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation","volume":"26","author":"Wenger","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00007890-200007270-00006","article-title":"Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation","volume":"70","author":"Cooke","year":"2000","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bjh.16621","article-title":"Endothelial cell function and endothelial\u2010related disorders following haematopoietic cell transplantation","volume":"190","author":"Hildebrandt","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.rmed.2025.108336_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/bbmt.2002.v8.pm12171486","article-title":"Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Yanik","year":"2002","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbmt.2014.09.019","article-title":"TNF-receptor inhibitor therapy for the treatment of children with idiopathic pneumonia syndrome. A joint Pediatric Blood and Marrow Transplant Consortium and Children's Oncology Group Study (ASCT0521)","volume":"21","author":"Yanik","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib28","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41409-017-0042-z","article-title":"Endothelial cell damage in idiopathic pneumonia syndrome","volume":"53","author":"Altmann","year":"2018","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib29","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/trf.12396","article-title":"The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation","volume":"54","author":"Vande","year":"2014","journal-title":"Transfusion (Paris)"},{"issue":"8","key":"10.1016\/j.rmed.2025.108336_bib30","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood-2003-05-1597","article-title":"Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation","volume":"102","author":"Fukuda","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2018.09.002","article-title":"Influence of total body irradiation dose rate on idiopathic pneumonia syndrome in acute leukemia patients undergoing allogeneic hematopoietic cell transplantation","volume":"103","author":"Gao","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib32","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.crad.2016.06.109","article-title":"High-resolution CT findings of idiopathic pneumonia syndrome after haematopoietic stem cell transplantation: based on the updated concept of idiopathic pneumonia syndrome by the American Thoracic Society in 2011","volume":"71","author":"Tanaka","year":"2016","journal-title":"Clin. Radiol."},{"issue":"24","key":"10.1016\/j.rmed.2025.108336_bib33","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1182\/blood-2014-12-617035","article-title":"Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies","volume":"125","author":"Seo","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.rmed.2025.108336_bib34","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bbmt.2012.05.012","article-title":"HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation","volume":"18","author":"Zerr","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1164\/rccm.201809-1635OC","article-title":"First-onset herpesviral infection and lung injury in allogeneic hematopoietic cell transplantation","volume":"200","author":"Zhou","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.rmed.2025.108336_bib36","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1182\/blood-2008-03-143412","article-title":"The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation","volume":"112","author":"Yanik","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib37","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbmt.2014.02.026","article-title":"Randomized, double-blind, placebo-controlled trial of soluble tumor necrosis factor receptor: enbrel (etanercept) for the treatment of idiopathic pneumonia syndrome after allogeneic stem cell transplantation: blood and marrow transplant clinical trials ne","volume":"20","author":"Yanik","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"12","key":"10.1016\/j.rmed.2025.108336_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5242","article-title":"Successful ruxolitinib administration for a patient with steroid\u2010refractory idiopathic pneumonia syndrome following hematopoietic stem cell transplantation: a case report and literature review","volume":"9","author":"Tomomasa","year":"2021","journal-title":"Clin Case Rep"},{"issue":"9","key":"10.1016\/j.rmed.2025.108336_bib39","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1038\/s41409-021-01293-y","article-title":"Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation","volume":"56","author":"Wu","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1164\/rccm.200112-141CC","article-title":"Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients","volume":"166","author":"Afessa","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib41","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood.2023023249","article-title":"How I diagnose and treat organizing pneumonia in hematopoietic cell transplant recipients","volume":"144","author":"Lai","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib42","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1378\/chest.08-2084","article-title":"Diffuse alveolar hemorrhage","volume":"137","author":"Lara","year":"2010","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2025.108336_bib43","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3324\/haematol.2018.189134","article-title":"Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics","volume":"103","author":"Keklik","year":"2018","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib44","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.bbmt.2006.06.002","article-title":"Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes","volume":"12","author":"Majhail","year":"2006","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib45","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/bmt.2014.287","article-title":"Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage","volume":"50","author":"Rathi","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib46","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1182\/blood-2002-06-1813","article-title":"Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants","volume":"102","author":"Freudenberger","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib47","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/bmt.2013.116","article-title":"Pre-transplant risk factors for cryptogenic organizing pneumonia\/bronchiolitis obliterans organizing pneumonia after hematopoietic cell transplantation","volume":"48","author":"Nakasone","year":"2013","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib48","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s12185-019-02643-9","article-title":"Patterns of onset and outcome of cryptogenic organizing pneumonia after allogeneic hematopoietic stem cell transplantation","volume":"109","author":"Adachi","year":"2019","journal-title":"Int. J. Hematol."},{"issue":"9","key":"10.1016\/j.rmed.2025.108336_bib49","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00277-019-03746-3","article-title":"Bronchoscopic features, associations, and outcomes of organizing pneumonia following allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Brownback","year":"2019","journal-title":"Ann. Hematol."},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-246119","article-title":"Organising pneumonia manifesting as a late-phase complication of COVID-19","volume":"14","author":"Ng","year":"2021","journal-title":"BMJ Case Rep."},{"issue":"1017","key":"10.1016\/j.rmed.2025.108336_bib51","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1259\/bjr\/54532316","article-title":"The reversed halo sign: update and differential diagnosis","volume":"85","author":"Godoy","year":"2012","journal-title":"Br. J. Radiol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.chest.2021.12.659","article-title":"Algorithmic approach to the diagnosis of organizing pneumonia","volume":"162","author":"Cherian","year":"2022","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198501173120304","article-title":"Bronchiolitis obliterans organizing pneumonia","volume":"312","author":"Epler","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.rmed.2025.108336_bib54","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00277-022-04868-x","article-title":"Significance of alveolar nitric oxide concentration in the airway of patients with organizing pneumonia after allogeneic hematopoietic stem cell transplantation","volume":"101","author":"Kajimura","year":"2022","journal-title":"Ann. Hematol."},{"issue":"7","key":"10.1016\/j.rmed.2025.108336_bib55","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1097\/MPH.0000000000001566","article-title":"A case of pulmonary veno-occlusive disease following hepatic veno-occlusive disease after autologous hematopoietic stem cell transplantation for neuroblastoma","volume":"42","author":"Isshiki","year":"2020","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.rmed.2025.108336_bib56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/sj.bmt.1705990","article-title":"Pulmonary veno-occlusive disease following hematopoietic stem cell transplantation: a rare model of endothelial dysfunction","volume":"41","author":"Bunte","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0925-5710(96)00467-7","article-title":"Pulmonary veno-occlusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia","volume":"64","author":"Kuga","year":"1996","journal-title":"Int. J. Hematol."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib58","doi-asserted-by":"crossref","first-page":"9811","DOI":"10.2169\/internalmedicine.9811-22","article-title":"Pulmonary veno-occlusive disease that developed following hematopoietic stem cell transplantation for acute myeloid leukemia","volume":"62","author":"Takeda","year":"2023","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib59","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/j.chest.2019.11.021","article-title":"Venoocclusive disease with both hepatic and pulmonary involvement","volume":"157","author":"Tissot","year":"2020","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1702137","article-title":"Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantation","volume":"25","author":"Woodard","year":"2000","journal-title":"Bone Marrow Transplant."},{"issue":"8","key":"10.1016\/j.rmed.2025.108336_bib61","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00000478-200008000-00013","article-title":"Pulmonary cytolytic thrombi","volume":"24","author":"Gulbahce","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib62","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/bmt.2010.119","article-title":"Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant","volume":"46","author":"Smith","year":"2011","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00043426-200301000-00019","article-title":"Pulmonary cytolytic thrombi: unusual complication of hematopoietic stem cell transplantation","volume":"25","author":"Morales","year":"2003","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.rmed.2025.108336_bib64","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.1002\/ajh.24435","article-title":"Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation","volume":"91","author":"Modi","year":"2016","journal-title":"Am. J. Hematol."},{"issue":"8","key":"10.1016\/j.rmed.2025.108336_bib65","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/bmt.2015.105","article-title":"Chronic GvHD-associated serositis and pericarditis","volume":"50","author":"Leonard","year":"2015","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib66","first-page":"207","article-title":"Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease","volume":"17","author":"Seber","year":"1996","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.rmed.2025.108336_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1546599","article-title":"Case Report: diagnosis and successful treatment of a rare case of steroid-refractory chronic graft-vs-host disease-related serositis","volume":"16","author":"Xiong","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.rmed.2025.108336_bib68","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jtct.2022.05.038","article-title":"Toward a better understanding of the atypical features of chronic graft-versus-host disease: a report from the 2020 national institutes of health consensus project task force","volume":"28","author":"Cuvelier","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib69","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/0003-4819-77-4-507","article-title":"Pleural effusions: the diagnostic separation of transudates and exudates","volume":"77","author":"Light","year":"1972","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib70","doi-asserted-by":"crossref","first-page":"368","DOI":"10.7326\/0003-4819-111-5-368","article-title":"Obstructive lung disease after allogeneic marrow transplantation","volume":"111","author":"Clark","year":"1989","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.rmed.2025.108336_bib71","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.bbmt.2010.11.018","article-title":"Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation","volume":"17","author":"Au","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib72","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/bmt.2014.25","article-title":"Bronchiolitis obliterans in patients undergoing allogeneic hematopoietic SCT","volume":"49","author":"Vieira","year":"2014","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib73","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1378\/chest.101.3.775","article-title":"Bronchiolitis obliterans after autologous bone marrow transplantation","volume":"101","author":"Paz","year":"1992","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.rmed.2025.108336_bib74","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1513\/AnnalsATS.201604-262OC","article-title":"Lung function trajectory in bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplant","volume":"13","author":"Cheng","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmed.2025.108336_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106608","article-title":"Relationship between FEV1 decline and mortality in patients with bronchiolitis obliterans syndrome\u2014a systematic literature review","volume":"188","author":"Kemp","year":"2021","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib76","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib77","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1378\/chest.128.1.153","article-title":"Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia","volume":"128","author":"Tomas","year":"2005","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rmed.2025.108336_bib78","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/sj.bmt.1704985","article-title":"Lower incidence of Bronchiolitis obliterans in allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning compared with myeloablative conditioning","volume":"35","author":"Yoshihara","year":"2005","journal-title":"Bone Marrow Transplant."},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib79","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1083-8791(03)00242-8","article-title":"Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes","volume":"9","author":"Dudek","year":"2003","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib80","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.200212-1468OC","article-title":"Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation","volume":"168","author":"Chien","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib81","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbmt.2019.12.002","article-title":"Early post-transplantation spirometry is associated with the development of bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation","volume":"26","author":"Jamani","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib82","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbmt.2009.12.534","article-title":"Strong association between respiratory viral infection early after hematopoietic stem cell transplantation and the development of life-threatening acute and chronic alloimmune lung syndromes","volume":"16","author":"Versluys","year":"2010","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41409-023-02151-9","article-title":"Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"59","author":"Huang","year":"2024","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib84","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.bbmt.2015.02.006","article-title":"Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung","volume":"21","author":"Abedin","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib85","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.bbmt.2015.12.023","article-title":"Correlation and agreement of handheld spirometry with laboratory spirometry in allogeneic hematopoietic cell transplant recipients","volume":"22","author":"Cheng","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib86","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1164\/rccm.200307-1018OC","article-title":"The predictive value of bronchiolitis obliterans syndrome stage 0-p","volume":"169","author":"Hachem","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib87","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1513\/AnnalsATS.202005-434RL","article-title":"Feasibility and reliability of home-based spirometry telemonitoring in allogeneic hematopoietic cell transplant recipients","volume":"17","author":"Sheshadri","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"10.1016\/j.rmed.2025.108336_bib88","doi-asserted-by":"crossref","first-page":"616.e1","DOI":"10.1016\/j.jtct.2021.03.024","article-title":"Home spirometry telemonitoring for early detection of bronchiolitis obliterans syndrome in patients with chronic graft-versus-host disease","volume":"27","author":"Turner","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib89","doi-asserted-by":"crossref","first-page":"204.e1","DOI":"10.1016\/j.jtct.2022.12.001","article-title":"Risk factors for bronchiolitis obliterans syndrome after initial detection of pulmonary impairment after hematopoietic cell transplantation","volume":"29","author":"Alkhunaizi","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib90","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1148\/radiology.216.2.r00au21472","article-title":"Early bronchiolitis obliterans following lung transplantation: accuracy of expiratory thin-section CT for diagnosis","volume":"216","author":"Lee","year":"2000","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.rmed.2025.108336_bib91","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1111\/ajt.15814","article-title":"Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"20","author":"Cheng","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib92","doi-asserted-by":"crossref","first-page":"A6448","DOI":"10.1016\/j.chest.2023.07.4159","article-title":"Distinguishing early bronchiolitis obliterans syndrome after hematopoietic cell transplantation using novel lung strain metrics from chest CT scans","volume":"164","author":"Sharifi","year":"2023","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.rmed.2025.108336_bib93","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.bbmt.2019.06.026","article-title":"Therapeutic impact and complications associated with surgical lung biopsy after allogeneic hematopoietic stem cell transplantation in children","volume":"25","author":"Dieffenbach","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib94","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jpedsurg.2018.02.069","article-title":"Surgical lung biopsy in children after hematopoietic cell transplantation","volume":"53","author":"Ortega-Laureano","year":"2018","journal-title":"J. Pediatr. Surg."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib95","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bmt.2017.238","article-title":"Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation","volume":"53","author":"O'Dwyer","year":"2018","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib96","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbmt.2013.03.017","article-title":"Lung histology predicts outcome of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"19","author":"Holbro","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib97","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/his.13697","article-title":"Lung histopathology of non\u2010infectious pulmonary complications after allogeneic haematopoietic stem cell transplantation","volume":"73","author":"Meignin","year":"2018","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib98","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bbmt.2014.12.004","article-title":"Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation","volume":"21","author":"Uhlving","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib99","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bmt.1705877","article-title":"Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation","volume":"41","author":"Bashoura","year":"2008","journal-title":"Bone Marrow Transplant."},{"issue":"9","key":"10.1016\/j.rmed.2025.108336_bib101","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.bmt.1705637","article-title":"Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation","volume":"39","author":"Bergeron","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib102","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbmt.2015.10.009","article-title":"Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation","volume":"22","author":"Williams","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.rmed.2025.108336_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107410","article-title":"Efficacy of inhaled tiotropium add-on to budesonide\/formoterol in patients with bronchiolitis obliterans developing after hematopoietic stem cell transplantation","volume":"218","author":"Lim","year":"2023","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib104","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13063-024-08051-7","article-title":"A placebo-controlled, crossover trial to investigate the efficacy of tiotropium bromide or placebo added to usual care in stable symptomatic post-hematopoietic stem cell transplantation (HSCT) bronchiolitis obliterans syndrome (BOS)","volume":"25","author":"Dini","year":"2024","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12931-016-0380-1","article-title":"Therapeutic effect of budesonide\/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"17","author":"Kim","year":"2016","journal-title":"Respir. Res."},{"issue":"12","key":"10.1016\/j.rmed.2025.108336_bib106","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/bmt.2011.1","article-title":"Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT\u2014a randomized double-blinded placebo-controlled study","volume":"46","author":"Lam","year":"2011","journal-title":"Bone Marrow Transplant."},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib107","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jama.2017.9938","article-title":"Effect of azithromycin on airflow decline\u2013free survival after allogeneic hematopoietic stem cell transplant","volume":"318","author":"Bergeron","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib108","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbmt.2019.10.025","article-title":"Azithromycin use and increased cancer risk among patients with bronchiolitis obliterans after hematopoietic cell transplantation","volume":"26","author":"Cheng","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib109","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41409-020-01073-0","article-title":"Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients","volume":"56","author":"Sheshadri","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"21","key":"10.1016\/j.rmed.2025.108336_bib110","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2017-07-793786","article-title":"Ibrutinib for chronic graft-versus-host disease after failure of prior therapy","volume":"130","author":"Miklos","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib111","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.22.00509","article-title":"Ibrutinib for first-line treatment of chronic graft-versus-host disease: results from the randomized phase III iNTEGRATE study","volume":"41","author":"Miklos","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"Supplement 1","key":"10.1016\/j.rmed.2025.108336_bib112","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2023-179365","article-title":"A phase II multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation","volume":"142","author":"Defilipp","year":"2023","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.rmed.2025.108336_bib113","doi-asserted-by":"crossref","first-page":"6263","DOI":"10.1182\/bloodadvances.2022008095","article-title":"Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials","volume":"6","author":"DeFilipp","year":"2022","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.rmed.2025.108336_bib114","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41409-022-01716-4","article-title":"The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial","volume":"57","author":"Matthaiou","year":"2022","journal-title":"Bone Marrow Transplant."},{"issue":"11","key":"10.1016\/j.rmed.2025.108336_bib115","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJMoa2401537","article-title":"Axatilimab in recurrent or refractory chronic graft-versus-host disease","volume":"391","author":"Wolff","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.rmed.2025.108336_bib116","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.bbmt.2018.04.012","article-title":"Extracorporeal photopheresis improves survival in hematopoietic cell transplant patients with bronchiolitis obliterans syndrome without significantly impacting measured pulmonary functions","volume":"24","author":"Hefazi","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib117","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/bmt.2010.152","article-title":"Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT","volume":"46","author":"Lucid","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.rmed.2025.108336_bib118","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2017.14448","article-title":"Lessons from the discontinuation of extracorporeal photopheresis","author":"Brownback","year":"2017","journal-title":"Swiss Med. Wkly."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib119","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jca.21404","article-title":"Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantation","volume":"31","author":"Brownback","year":"2016","journal-title":"J. Clin. Apher."},{"issue":"8","key":"10.1016\/j.rmed.2025.108336_bib120","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.bbmt.2012.01.017","article-title":"Pulmonary rehabilitation for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation","volume":"18","author":"Tran","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"12","key":"10.1016\/j.rmed.2025.108336_bib121","doi-asserted-by":"crossref","first-page":"659","DOI":"10.21037\/atm-22-2517","article-title":"Lung transplantation for bronchiolitis obliterans after hematopoietic stem cell transplantation: a retrospective single-center study","volume":"10","author":"Liang","year":"2022","journal-title":"Ann. Transl. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108336_bib122","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib123","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41409-019-0636-8","article-title":"Pleuroparenchymal fibroelastosis after allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Bondeelle","year":"2020","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.rmed.2025.108336_bib124","article-title":"Pleuroparenchymal fibroelastosis secondary to autologous peripheral blood stem cell transplantation: a case report","volume":"43","author":"Egashira","year":"2023","journal-title":"Respir Med Case Rep"},{"issue":"9","key":"10.1016\/j.rmed.2025.108336_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.1201","article-title":"Extremely late\u2010onset chronic graft\u2010versus\u2010host disease presenting with bronchiolitis obliterans and pleuroparenchymal fibroelastosis","volume":"11","author":"Akiyama","year":"2023","journal-title":"Respirol Case Rep"},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib126","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.resinv.2019.04.003","article-title":"Cause of pleuroparenchymal fibroelastosis following allogeneic hematopoietic stem cell transplantation","volume":"57","author":"Higo","year":"2019","journal-title":"Respir Investig"},{"issue":"10","key":"10.1016\/j.rmed.2025.108336_bib127","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.rmed.2014.09.006","article-title":"Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation","volume":"108","author":"Schlemmer","year":"2014","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib128","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1038\/s41598-022-10932-3","article-title":"Clinical characteristics and treatment of elderly onset adult-onset Still's disease","volume":"12","author":"Kishida","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41409-022-01859-4","article-title":"Interstitial lung diseases after hematopoietic stem cell transplantation: new pattern of lung chronic graft-versus-host disease?","volume":"58","author":"Archer","year":"2023","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib130","first-page":"258","article-title":"Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: incidence, predictors and outcome","volume":"91","author":"Skert","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.rmed.2025.108336_bib131","doi-asserted-by":"crossref","DOI":"10.1177\/11795476221097317","article-title":"Fibrotic cystic lung disease post hematopoietic stem cell transplant: who is the culprit?","volume":"15","author":"Alam","year":"2022","journal-title":"Clin. Med. Insights Case Rep."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib132","first-page":"329","article-title":"Acute and chronic pulmonary complications following autologous bone marrow transplantation in non-Hodgkin\u2019s lymphoma","volume":"6","author":"Jochelson","year":"1990","journal-title":"Bone Marrow Transplant."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib133","article-title":"Risk factors and clinical features for post-transplant thoracic air-leak syndrome in adult patients receiving allogeneic haematopoietic stem cell transplantation","volume":"9","author":"Liu","year":"2019","journal-title":"Sci. Rep."},{"issue":"20","key":"10.1016\/j.rmed.2025.108336_bib134","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000019948","article-title":"Clinical and imaging characteristics of hematologic disease complicated by air leak syndrome","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib135","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3346\/jkms.2010.25.5.658","article-title":"Thoracic air-leak syndromes in hematopoietic stem cell transplant recipients with graft-versus-host disease: a possible sign for poor response to treatment and poor prognosis","volume":"25","author":"Moon","year":"2010","journal-title":"J. Kor. Med. Sci."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib136","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00408-018-0173-z","article-title":"Thoracic air-leak syndrome complicating allogeneic hematopoietic stem-cell transplantation","volume":"197","author":"Boghanim","year":"2019","journal-title":"Lung"},{"issue":"11","key":"10.1016\/j.rmed.2025.108336_bib137","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1002\/ppul.26645","article-title":"Recurrent thoracic air leak syndrome in patients affected by pulmonary graft\u2010versus\u2010host disease: surgical strategies and outcome","volume":"58","author":"Persano","year":"2023","journal-title":"Pediatr. Pulmonol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib138","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01324-2024","article-title":"Definition, classification and diagnosis of pulmonary hypertension","volume":"64","author":"Kovacs","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib139","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00612-2019","article-title":"Pulmonary hypertension after bone marrow transplantation in children","volume":"54","author":"Levy","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108336_bib140","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1415984","article-title":"Pulmonary hypertension in the intensive care unit after pediatric allogeneic hematopoietic stem cell transplant: incidence, risk factors, and outcomes","volume":"14","author":"Smith","year":"2024","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib141","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41409-019-0741-8","article-title":"Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis","volume":"55","author":"Gupta","year":"2020","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib142","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood-2007-10-117051","article-title":"The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention","volume":"112","author":"Gerber","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib143","doi-asserted-by":"crossref","first-page":"111.e1","DOI":"10.1016\/j.jtct.2024.10.016","article-title":"Venous thromboembolism incidence and risk factors in patients undergoing hematopoietic stem cell transplantation","volume":"31","author":"Benfield","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib144","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/a-2365-8883","article-title":"Venous thromboembolism post-allogeneic hematopoietic cell transplant: risk factors, incidence, and outcomes","volume":"125","author":"Granat","year":"2025","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.rmed.2025.108336_bib145","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.thromres.2016.02.016","article-title":"Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center","volume":"142","author":"Labrador","year":"2016","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.rmed.2025.108336_bib146","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3324\/haematol.2017.164012","article-title":"Venous thromboembolism is associated with graft- versus -host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation","volume":"102","author":"Kekre","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib147","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40257-017-0306-9","article-title":"Cutaneous graft-versus-host disease: diagnosis and treatment","volume":"19","author":"Strong Rodrigues","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108336_bib148","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.bbmt.2011.10.021","article-title":"Fibrotic and sclerotic manifestations of chronic graft-versus-host disease","volume":"18","author":"Kitko","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"25","key":"10.1016\/j.rmed.2025.108336_bib149","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1182\/blood-2012-10-464198","article-title":"Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease","volume":"121","author":"Inamoto","year":"2013","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.rmed.2025.108336_bib150","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires","year":"2011","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.rmed.2025.108336_bib151","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1182\/bloodadvances.2022008201","article-title":"Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease","volume":"6","author":"Sheshadri","year":"2022","journal-title":"Blood Adv."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib152","doi-asserted-by":"crossref","first-page":"255.e1","DOI":"10.1016\/j.jtct.2025.02.001","article-title":"Restrictive ventilatory defects following hematopoietic stem cell transplant are associated with increased mortality","volume":"31","author":"Alkhunaizi","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.rmed.2025.108336_bib153","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.bbmt.2014.07.001","article-title":"Incidence, risk factors, and long-term outcomes of sclerotic graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"20","author":"Uhm","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"7","key":"10.1016\/j.rmed.2025.108336_bib154","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.138.7.924","article-title":"Sclerodermatous graft-vs-host disease","volume":"138","author":"Pe\u00f1as","year":"2002","journal-title":"Arch. Dermatol."},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib155","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2214\/AJR.08.1699","article-title":"Musculocutaneous chronic graft-versus-host disease: MRI follow-up of patients undergoing immunosuppressive therapy","volume":"192","author":"Horger","year":"2009","journal-title":"Am. J. Roentgenol."},{"issue":"7","key":"10.1016\/j.rmed.2025.108336_bib156","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jtct.2021.03.033","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IIa. The 2020 clinical implementation and early diagnosis working group report","volume":"27","author":"Kitko","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.rmed.2025.108336_bib157","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0899-7071(01)00240-6","article-title":"CT and MRI findings in sclerodermatous chronic graft vs. host disease","volume":"25","author":"Dumford","year":"2001","journal-title":"Clin. Imag."},{"issue":"3","key":"10.1016\/j.rmed.2025.108336_bib158","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood-2009-02-204156","article-title":"Imatinib for refractory chronic graft-versus-host disease with fibrotic features","volume":"114","author":"Olivieri","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.rmed.2025.108336_bib159","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.15593","article-title":"Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft\u2010versus\u2010host disease","volume":"177","author":"Hurabielle","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.rmed.2025.108336_bib160","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1016\/j.bbmt.2018.06.035","article-title":"A prospective trial of extracorporeal photopheresis for chronic graft-versus-host disease reveals significant disease response and No association with frequency of regulatory T cells","volume":"24","author":"Gandelman","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"17","key":"10.1016\/j.rmed.2025.108336_bib161","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood-2015-10-678706","article-title":"Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism","volume":"127","author":"Flynn","year":"2016","journal-title":"Blood"},{"issue":"47","key":"10.1016\/j.rmed.2025.108336_bib162","doi-asserted-by":"crossref","first-page":"16814","DOI":"10.1073\/pnas.1414189111","article-title":"Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism","volume":"111","author":"Zanin-Zhorov","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"17","key":"10.1016\/j.rmed.2025.108336_bib163","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1200\/JCO.20.02754","article-title":"ROCK2 inhibition with belumosudil (KD025) for the treatment of chronic graft-versus-host disease","volume":"39","author":"Jagasia","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108336_bib164","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.apmr.2020.10.141","article-title":"Rehabilitation interventions in the multidisciplinary management of patients with sclerotic graft-versus-host disease of the skin and fascia","volume":"102","author":"Mol\u00e9s-Poveda","year":"2021","journal-title":"Arch. Phys. Med. Rehabil."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125003993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125003993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:09:32Z","timestamp":1761116972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125003993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":164,"alternative-id":["S0954611125003993"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108336","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninfectious pulmonary complications after hematopoietic cell transplantation: a comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108336"}}